DJIA 17,031.14 43.63 0.26%
NASDAQ 4,518.90 -48.70 -1.07%
S&P 500 1,984.13 -1.41 -0.07%
market minute promo

Celgene (NASDAQ: CELG)

89.46 -2.06 (-2.25%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

CELG $89.46 -2.25%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $91.00
Previous Close $91.52
Daily Range $88.22 - $91.05
52-Week Range $66.85 - $96.44
Market Cap $71.5B
P/E Ratio 52.90
Dividend (Yield) $0.00 (0.0%)
Volume 4,912,924
Average Daily Volume 3,758,655
Current FY EPS $3.20





Celgene (CELG) Description

A biopharmaceutical company primarily engaged in the discovery, development and commercialization of innovative therapies designed to treat cancer and immune-inflammatory related diseases. Website:

News & Commentary

These 7 States Have the Highest Rates of Pancreatic Cancer

Pancreatic cancer is arguably the most lethal form of the disease. Find out which seven states this disease occurs in most often, as well as what new pathways are being tested to treat this terrible disease.

Jim Cramer's 'Mad Money' Recap: Time to Make Room for Alibaba

3 Stocks Underperforming Today In The Drugs Industry

Celgene Looks Unstoppable

3 Companies Investing In Stem Cell Research

Medivation Eyes Blockbuster As Cancer Drug Gets An OK

Trading Guidelines for Amgen, Biogen Idec, Gilead, 3 Other Biotechs

Short Sellers Remain Vigilant Against Biotechs

Why Celgene's Stock is up 11% in 2014

Celgene has gained ground this year thanks to steady growth of Revlimid, Abraxane, and Pomalyst, but it may be Otezla that could push shares up into the end of the year.

Celgene Corporation Easing Back After Run To New All-Time Highs - Is It Buyable Yet?

See More CELG News...

CELG's Top Competitors

CELG $89.46 (-2.25%)
Current stock: CELG
AMGN $137.97 (0.06%)
Current stock: AMGN
GILD $100.99 (-2.58%)
Current stock: GILD
$0.00 (0.00%)
Current stock: